4//SEC Filing
Zuga Matt 4
Accession 0001576885-25-000037
CIK 0001576885other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 9:19 PM ET
Size
7.6 KB
Accession
0001576885-25-000037
Insider Transaction Report
Form 4
Zuga Matt
CFO & Chief Business Officer
Transactions
- Sale
Common Stock
2025-01-21$1.60/sh−4,364$6,986→ 260,646 total - Sale
Common Stock
2025-01-23$1.72/sh−28,902$49,633→ 231,744 total
Footnotes (4)
- [F1]Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024.
- [F2]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.5800 to $1.6100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Represents the number of shares sold by the Reporting Person in connection with the vesting of RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 24, 2024.
- [F4]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.6705 to $1.7699. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Acumen Pharmaceuticals, Inc.
CIK 0001576885
Entity typeother
Related Parties
1- filerCIK 0001790214
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 9:19 PM ET
- Size
- 7.6 KB